BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 19, 1999
View Archived Issues
New mediator of allergic asthma revealed in studies using interleukin-13 fusion protein
Read More
AMPA antagonists and their use described by Pfizer
Read More
Tricyclic antiproliferative agents revealed by Schering-Plough
Read More
Cancer Research Campaign Technology evaluates new antitumor trimelamol analogues
Read More
New broad-spectrum antibacterial series patented by Bayer
Read More
Cyanoenamines as potassium channel modulators
Read More
Roche presents new compound for hyperproliferative skin disorders
Read More
Licensing opportunity announced: liposomal compound for treatment of ARDS
Read More
AstraZeneca merger proceedings under way
Read More
New indication approved for Livial, a tissue-specific treatment for menopausal symptoms
Read More
Results from large study comparing atovaquone and dapsone for PCP prophylaxis published
Read More
Different concentrations of olopatadine compared to placebo for preventing allergic conjunctivitis
Read More
Z-335 characterized as potent, orally effective and long-acting antiplatelet/antithrombotic agent
Read More
Targeted Genetics, Sangamo combine two novel technologies for drug discovery
Read More
La Jolla reports progress on three fronts at H&Q conference
Read More
InKine investigates Syk kinase inhibitors for asthma, other inflammatory conditions
Read More
Watson completes TheraTech acquisition
Read More
Knoll's antiobesity drug Reductil approved in Germany
Read More
Relationship between antitumor activity of bombesin/GRP antagonists and effects on EGF receptors
Read More
Antiidiotype MAb in development by Immune Network Research receives patent coverage
Read More
Besins Iscovesco provides funds to speed development of Andractim
Read More
LeukoSite, Warner-Lambert collaborate on integrin antagonist research
Read More
Takeda submits NDA for type II diabetes treatment
Read More
Dose of O6-benzylguanine for use with BCNU in brain cancer patients determined
Read More
Cell Pathways explores SAANDs as new class of anticancer drugs; patent issues in U.S.
Read More
Allelix: Q1 1999 highlights
Read More
Oral heparin shown equivalent in efficacy and safety to injectable heparin
Read More
New neurological and immunological therapies basis of Neurocrine Biosciences-Caliper collaboration
Read More